First Trust Advisors
LFCR icon

First Trust Advisors’s Lifecore Biomedical LFCR Stock Holding History

First Trust Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-58,513
Closed -$466K – 2413
2020
Q2 		$466K Buy
58,513
+4,186
+8% +$43.2K ﹤0.01% 2038
2020
Q1 		$472K Sell
54,327
-10,535
-16% -$110K ﹤0.01% 1966
2019
Q4 		$734K Sell
64,862
-1,257
-2% -$13.4K ﹤0.01% 1997
2019
Q3 		$719K Buy
66,119
+13,277
+25% +$145K ﹤0.01% 1994
2019
Q2 		$495K Sell
52,842
-332
-0.6% -$3.35K ﹤0.01% 2132
2019
Q1 		$653K Buy
53,174
+3,150
+6% +$38.5K ﹤0.01% 2034
2018
Q4 		$592K Buy
50,024
+7,897
+19% +$108K ﹤0.01% 2072
2018
Q3 		$607K Buy
42,127
+10,891
+35% +$151K ﹤0.01% 2138
2018
Q2 		$465K Buy
31,236
+4,789
+18% +$66.5K ﹤0.01% 2175
2018
Q1 		$345K Buy
26,447
+1,824
+7% +$24K ﹤0.01% 2118
2017
Q4 		$310K Buy
24,623
+2,893
+13% +$36.6K ﹤0.01% 2229
2017
Q3 		$281K Buy
+21,730
New +$286K ﹤0.01% 2250
2016
Q3 		– Sell
-13,973
Closed -$150K – 2351
2016
Q2 		$150K Sell
13,973
-887
-6% -$9.79K ﹤0.01% 2209
2016
Q1 		$156K Sell
14,860
-317
-2% -$3.48K ﹤0.01% 2164
2015
Q4 		$180K Sell
15,177
-235
-2% -$2.89K ﹤0.01% 2166
2015
Q3 		$180K Buy
15,412
+1,479
+11% +$19.6K ﹤0.01% 2180
2015
Q2 		$201K Buy
13,933
+6
+0% +$87 ﹤0.01% 2162
2015
Q1 		$194K Sell
13,927
-39
-0.3% -$539 ﹤0.01% 2163
2014
Q4 		$193K Sell
13,966
-1,264
-8% -$16.3K ﹤0.01% 2176
2014
Q3 		$187K Sell
15,230
-540
-3% -$6.74K ﹤0.01% 2147
2014
Q2 		$197K Sell
15,770
-6,767
-30% -$79.6K ﹤0.01% 2149
2014
Q1 		$252K Buy
22,537
+478
+2% +$5.24K ﹤0.01% 2131
2013
Q4 		$267K Sell
22,059
-14,395
-39% -$172K ﹤0.01% 2084
2013
Q3 		$445K Buy
36,454
+3,738
+11% +$52.2K ﹤0.01% 1956
2013
Q2 		$432K Buy
+32,716
New +$452K ﹤0.01% 1875

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

First Trust Advisors's LFCR Position: Q3 2020 in Review

First Trust Advisors sold out of Lifecore Biomedical (LFCR) in Q3 2020, closing a stake of 58,513 shares — an estimated $466K sold.

First Trust Advisors first reported a position in LFCR in Q2 2013 and held it in 25 quarters. The position peaked at $734K in Q4 2019. 96 funds tracked by Wall St. Rank hold LFCR as of Q3 2020.

  • First Trust Advisors reported no remaining Lifecore Biomedical position as of Q3 2020 after selling out during the quarter.
  • First Trust Advisors sold 58,513 Lifecore Biomedical shares in Q3 2020, an estimated $466K.
  • First Trust Advisors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 25 quarters.
  • First Trust Advisors's Lifecore Biomedical position peaked at $734K in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2020.

Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.